MEDAX | MEDBX | MEDAX / MEDBX | |
Total Expense Ratio | 1.06 | 1.81 | 59% |
Annual Report Gross Expense Ratio | 1.07 | 1.82 | 59% |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 6.411 | 5.931 | 108% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.45B | 7.45B | 100% |
Annual Yield % from dividends | 5.63 | 4.89 | 115% |
Returns for 1 year | 8.52 | 7.69 | 111% |
Returns for 3 years | 24.10 | 21.32 | 113% |
Returns for 5 years | 8.52 | 4.58 | 186% |
Returns for 10 years | 41.75 | 31.54 | 132% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JVMSX | 28.72 | N/A | N/A |
JHancock Disciplined Value Mid Cap R2 | |||
MAPCX | 15.30 | N/A | N/A |
BlackRock Sustainable Em Mkts Eq Ins | |||
MMPCX | 20.83 | N/A | N/A |
NYLI WMC Value Class C | |||
MIRSX | 21.76 | N/A | N/A |
Victory Integrity Small/Mid-Cap Value R6 | |||
APHGX | 26.37 | -0.14 | -0.53% |
Artisan Global Value Institutional |